Search bioRxiv⌕ Search

Biology subjects

Constantin, D.

Publications and source records attributed to Constantin, D..

2 recordsLinked to original sources

Exercise induces Skeletal Muscle Methylome and Transcriptome changes, regardless of Age and COPD

Skeletal muscle atrophy and deconditioning contribute to functional limitation and disability in COPD. While transcriptome and DNA methylation changes accompany exercise in healthy muscle, their interaction with COPD status and ageing, and integrative analyses of methylome-transcriptome responses have not been explored. We performed gene expression and DNA methylation profiling in skeletal muscle of sedentary volunteers with COPD, age-matched older adults, and younger healthy individuals, before and during (1,4 and 8 weeks) supervised aerobic exercise training and after four weeks of detraining. Exercise induced transcriptomic and DNA methylation changes, but these responses were unaffected by COPD status or age. Subsequent analysis focusing on temporal exercise effects independent of disease or age revealed differential transcriptomic changes across time points, a subset of which significantly associated with DNA methylome alterations. Transient transcriptomic changes not linked to DNA methylation were enriched for inflammatory and oxidative stress pathways, whereas persistent methylation-associated adaptations were related to immunomodulation and tissue remodelling. Together, this study provides insight into molecular mechanisms contributing to skeletal muscle adaptation to aerobic exercise training in sedentary individuals.

genomics↗

ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin's lymphoma and testicular cancer cells

It is of clinical importance to identify biomarkers predicting the efficacy of DNA damaging drugs (genotoxins) so that non-responders are not unduly exposed to the deleterious effects of otherwise inefficient drugs. Using a whole genome CRISPR/Cas9 gene knockout approach we have identified that low levels of ASH2L cause resistance to genotoxins. ASH2L is a core component of the H3K4 methyl transferase complex. We show that ASH2L absence decreases cell proliferation and favors DNA repair upon genotoxin exposure. The cell models we have used are derived from cancers currently treated either partially (Hodgkins lymphoma), or entirely (testicular cancer) with genotoxins. For such cancers, ASH2L levels could be used as a biomarker to predict the response to genotoxins. Our data also indicate that patients with low ASH2L expressing tumors do not develop resistance to ATR inhibitors. In these patients, such inhibitors may represent an alternative treatment to DNA damaging drugs.

cancer biology↗